Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection.
Touyz
Rhian M
RM
D052242:Adiponectin / Q000494:pharmacology* / Q000627:therapeutic use; D000273:Adipose Tissue / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D050197:Atherosclerosis / Q000188:drug therapy; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D016209:Interleukin-8 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D054419:Receptors, Adiponectin; D011956:Receptors, Cell Surface / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000494:pharmacology
C475418:ADIPOR1 protein, human; C475420:ADIPOR2 protein, human; D052242:Adiponectin; D000893:Anti-Inflammatory Agents; D016209:Interleukin-8; D054419:Receptors, Adiponectin; D011956:Receptors, Cell Surface; D014409:Tumor Necrosis Factor-alpha